Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2007
10/10/2007CN101052635A Chemical compounds
10/10/2007CN101052384A Non-aqueous transdermal absorption prepn. contg. non-steroid antiphlogistic analgesic
10/10/2007CN101052377A A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability
10/10/2007CN101052376A Semi-solid delivery vehicle and pharmaceutical compositions
10/10/2007CN101050256A Method for preparing water-soluble resin latex in acrylic acid series in use for intestine soluble coating material for medication
10/10/2007CN101050243A Derivative of amphoteric chitosan, preparation method, and application in pharmacy
10/10/2007CN101050062A Method for preparing slow releasing carrier of medication of microcrystalline glass in series of calcium phosphate
10/10/2007CN101049505A Method for preparing medical use biological degradable hydrogel of containing cholic acid group
10/10/2007CN101049504A Carrier of liposome medication, and preparation method
10/10/2007CN101049503A Ground substance of plaster ointment, and preparing technique
10/10/2007CN101049467A Composition of Chinese traditional medicine for treating coronary heart disease, and preparation method
10/10/2007CN101049466A Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method
10/10/2007CN101049380A Enteric solubility soft capsule containing camellia oil, and preparation method
10/10/2007CN101049325A Method for preparing processed product of Chinese ephedra of Chinese traditional medicine
10/10/2007CN101049320A Buccal tablets of extractive of propolis alcohol
10/10/2007CN101049308A Solid dispersion containing rimonabant and polyethyleneglycol, preparation and medication application
10/10/2007CN101049307A Matrine eye drip liquid, and producing method
10/10/2007CN101049288A New preparation method for raising rate of packaging microspheres of naltrexone
10/10/2007CN101049286A Gel preparation of Ciclopirox Olamine
10/10/2007CN101049283A Slim and shaping frost, and preparation method
10/10/2007CN100341579C Method for preparing gene therapeutic tissue engineering stent
10/10/2007CN100341578C Anhydrous topical skin preparations
10/10/2007CN100341577C Transdermal absorption preparation
10/10/2007CN100341576C Adhesive patch
10/10/2007CN100341575C Water soluble dry compositions
10/10/2007CN100341567C Compositions for nasal administration of insulin
10/10/2007CN100341505C Methods of administering epothilone analogs for treatment of cancer
10/10/2007CN100341498C Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CN100341491C Film coating
10/10/2007CN100341488C Immune effervescent tablets for drinking water and its prepn. method
10/10/2007CN100341486C O/W emulsion composition and method of preparing same
10/10/2007CN100341485C Anticancer compositions
10/10/2007CN100341484C Partially biodegradable temperature and pH sensitive hydrogel
10/10/2007CN100341483C Improvements in or relating to delivery of oral drugs
10/10/2007CN100341412C Methods for preserving ophthalmic solutions and preserved ophtalmic solutions
10/09/2007US7279562 Rapamycin conjugates
10/09/2007US7279561 Anti-rapamycin monoclonal antibodies
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279179 Liposome-entrapped topoisomerase inhibitors
10/09/2007US7279176 Controlled NO release by administering a biocompatible, polymerizable, macromer having NO is complexed to it; the NO is released following polymerization in situ
10/09/2007US7279175 Reduce restenosis coating on medical device
10/09/2007US7279154 exhibit a pronounced thermoassociative behavior and are outstandingly suitable as thickeners
10/09/2007US7279152 Use of polyphosphate as a tooth erosion inhibitors in acidic compositions
10/09/2007US7279150 Nanoparticle emulsion; magnetic resonance imaging; antiinflammatory agents; antitumor agents
10/09/2007US7278843 Methods for fine powder formation
10/09/2007CA2368094C Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
10/09/2007CA2235811C Hybrid matrix implants and explants
10/09/2007CA2232855C Pharmaceutical formulation
10/09/2007CA2197062C Drug delivery composition containing chitosan or derivative thereof having a defined z. potential
10/04/2007WO2007111933A2 Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same
10/04/2007WO2007111375A1 Intraorally rapidly disintegrating tablet
10/04/2007WO2007111371A1 Agent for amelioration of hyperesthetic skin itching
10/04/2007WO2007111370A1 Agent for external application to the skin
10/04/2007WO2007111211A1 Polymer conjugate of taxane
10/04/2007WO2007111163A1 Nanocomposite particle
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110776A1 Storage of influenza vaccines without refrigeration
10/04/2007WO2007110003A2 Micellar carriers for drugs with anti-cancer activity
10/04/2007WO2007076144A3 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
10/04/2007WO2007072065A3 Silicone composition
10/04/2007WO2007058935A3 Ophthalmic composition for dry eye therapy
10/04/2007WO2007052152A3 Sertraline oral concentrate
10/04/2007WO2007039201A3 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
10/04/2007WO2007038172A3 Guanidinium carriers
10/04/2007WO2007034321A3 Wound-healing pharmaceutical compositions comprising at least one soluble dextran and at least one platelet-derived growth factor
10/04/2007WO2007034320A3 Pdgf amphiphilic polymer complex
10/04/2007WO2007030012A3 Extracellular matrix imaging
10/04/2007WO2007027565A3 Argatroban formulation comprising an acid as solubilizer
10/04/2007WO2007001744A3 Methods and compositions for enhancing vascular access
10/04/2007WO2006116156A3 Toxin peptides with extended blood halflife
10/04/2007WO2006110776A3 Polyethylene glycol cojugates of antimicrobial agents
10/04/2007WO2006099258A8 Tigecycline compositions and methods of preparation
10/04/2007WO2006094810A3 Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007WO2005016239A3 Molecules enhancing dermal delivery of influenza vaccines
10/04/2007WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies
10/04/2007WO2004069193A3 Methods and compositions for inhibiting cholesterol uptake
10/04/2007US20070232904 Application of Hyaluronic Acid to Sentinel Lymph Node Identification
10/04/2007US20070232704 Heat generating biocompatible ceramic materials for drug delivery
10/04/2007US20070232639 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
10/04/2007US20070232629 Adhesive Patch
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070232529 Active agent delivery systems and methods for protecting and administering active agents
10/04/2007US20070232524 Use of N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability
10/04/2007US20070231862 Peptide scaffolds for transfer of molecules into eukaryotic cells
10/04/2007US20070231591 Adhesive Material
10/04/2007US20070231418 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract
10/04/2007US20070231408 Colloidal metal compositions and methods
10/04/2007US20070231393 System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
10/04/2007US20070231385 Controlled Release Pharmaceutical Composition and a Process for Preparing the Same
10/04/2007US20070231382 Pharmaceutical composition
10/04/2007US20070231374 Composition Comprising Ether Lipid
10/04/2007US20070231369 Ruminant feed composition and method of making
10/04/2007US20070231367 Bitterness-masking particulate jelly beverage
10/04/2007US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition